ENANTA PHARMACEUTICALS INC (ENTA)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ENTA
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ENTA | President and Chief Executive Officer; President, Director and Chief Executive Officer | 68 | ["Business and scientific experience as a pharmaceutical executive", "Chief executive officer of a biotechnology company", "Director of several companies in the industry", "Entrepreneur in Residence at Oxford Bioscience Partners", "Senior Vice President, Research and Development Operations at Millennium Pharmaceuticals", "Senior Vice President, Drug Discovery and Preclinical Development at LeukoSite, Inc.", "Senior drug discovery positions at Abbott Laboratories"] | [] | 2025 |
Biography sourced from the proxy statement filing.
Jay R. Luly, Ph.D. has served as our President and Chief Executive Officer and as a member of our Board of Directors since July 2003. Prior to joining Enanta, Dr. Luly was an Entrepreneur in Residence at Oxford Bioscience Partners. Before joining Oxford in March 2002, Dr. Luly held the positions of Senior Vice President, Research and Development Operations and Senior Vice President, Discovery Strategy and Operations at Millennium Pharmaceuticals following Millennium s merger with LeukoSite, Inc., where he had served as Senior Vice President, Drug Discovery and Preclinical Development. Prior to joining LeukoSite, he held a number of senior drug discovery positions at Abbott Laboratories from 1983 to 1997. Dr. Luly received a B.S. from the University of Illinois at Urbana-Champaign and a Ph.D. in synthetic organic chemistry from the University of California, Berkeley. We believe that Dr. Luly is qualified to serve on our Board of Directors due to his service as our President and Chief Executive Officer and his extensive knowledge of our company and industry.